| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.983 | 17.402 | 3.578 | 1.772 | 4.001 | 2.024 | 206 | 710 | - | 663 |
| Total Income - EUR | 27.983 | 17.402 | 3.578 | 1.772 | 4.001 | 2.024 | 206 | 710 | - | 663 |
| Total Expenses - EUR | 27.127 | 19.635 | 2.973 | 2.382 | 3.018 | 2.701 | 1.804 | 542 | - | 484 |
| Gross Profit/Loss - EUR | 856 | -2.233 | 605 | -610 | 983 | -677 | -1.598 | 167 | - | 180 |
| Net Profit/Loss - EUR | 17 | -2.434 | 498 | -662 | 863 | -737 | -1.604 | 146 | - | 139 |
| Employees | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 0 | - | 0 |
Check the financial reports for the company - Pluri Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.294 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Current Assets | 3.807 | 1.926 | 2.388 | 1.675 | 2.548 | 1.918 | 309 | 477 | - | 1.399 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Cash | 3.807 | 1.926 | 2.388 | 1.675 | 2.548 | 1.918 | 309 | 477 | - | 1.399 |
| Shareholders Funds | 3.808 | 1.335 | 1.810 | 1.115 | 1.956 | 1.182 | -448 | -304 | - | 629 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | - | 80 |
| Debts | 1.293 | 591 | 578 | 561 | 592 | 736 | 757 | 781 | - | 770 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Pluri Med S.r.l.